Clarify Health Solutions

Clarify Health Solutions is an operating company, not an investment fund. Strategic and financial decisions are led by co-founder and CEO Jean Drouin, with the board including representatives from major investors such as KKR, Insight Partners, and SoftBank Vision Fund 2 following their respective funding rounds. The co-founders maintain executive control over product and commercial strategy.

Clarify Health has built a longitudinal dataset covering over 300 million de-identified patient lives, pulling from claims, clinical records, and social determinants data. The dataset stretches back to 2016 and forms the underlying analytics infrastructure for its Atlas Platform, which health systems and payers use for benchmarking, network design, and episode-based payment models. This data scale is among the largest independent assets in healthcare analytics (per public record, 2021).

Clarify sells primarily to large U.S. health systems and national health plans engaged in value-based contracting. Its platform is used for clinical variation reduction, network optimization, and managing downside risk in Medicare Advantage and commercial accountable care arrangements. The firm's pricing model is subscription-based, tied to the software platform and underlying data access.

Clarify Health is a venture-backed operating company, not a portfolio company of a single family office. KKR led its $57 million Series C in 2018, and SoftBank Vision Fund 2 led a $150 million Series D in 2021 that valued the firm at $1.4 billion (per Reuters, 2021). Insight Partners, Spark Capital, and Concord Health Partners are also notable investors. These firms hold board seats, but day-to-day operations remain with the founding team.

Clarify ingests de-identified claims data, electronic health record feeds, and social determinants information through partnerships with health plans, clearinghouses, and provider organizations. The firm does not collect data directly from patients. Its data ingestion and linking capability — capable of resolving a single patient's journey across multiple disconnected care sites — is the core technical moat. Specific data partner contracts are not publicly disclosed.